BSE - Delayed Quote INR

Dhanvantri Jeevan Rekha Limited (ZDHJERK.BO)

19.41
0.00
(0.00%)
At close: 10:14:59 AM GMT+5:30
Loading Chart for ZDHJERK.BO
  • Previous Close 19.41
  • Open 19.41
  • Bid 18.44 x --
  • Ask 19.32 x --
  • Day's Range 19.41 - 19.41
  • 52 Week Range 16.47 - 24.09
  • Volume 160
  • Avg. Volume 714
  • Market Cap (intraday) 79.55M
  • Beta (5Y Monthly) -0.05
  • PE Ratio (TTM) 21.33
  • EPS (TTM) 0.91
  • Earnings Date May 19, 2025 - May 23, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date Sep 15, 2011
  • 1y Target Est --

Dhanvantri Jeevan Rekha Limited provides medical and healthcare services in India. The company offers diagnostic and therapeutic services. It provides specialty services, such as cardiology, gastroenterology, neurology, urology, and other diagnostic services. In addition, the company operates a cath lab that provides angiography, angioplasty, pacemaker implantation, valvuloplasty services, etc. Dhanvantri Jeevan Rekha Limited was incorporated in 1993 and is based in Meerut, India.

www.djrl.org.in

98

Full Time Employees

March 31

Fiscal Year Ends

Recent News: ZDHJERK.BO

View More

Performance Overview: ZDHJERK.BO

Trailing total returns as of 5/14/2025, which may include dividends or other distributions. Benchmark is S&P BSE SENSEX (^BSESN) .

YTD Return

ZDHJERK.BO
13.23%
S&P BSE SENSEX (^BSESN)
4.08%

1-Year Return

ZDHJERK.BO
15.61%
S&P BSE SENSEX (^BSESN)
11.25%

3-Year Return

ZDHJERK.BO
15.61%
S&P BSE SENSEX (^BSESN)
54.05%

5-Year Return

ZDHJERK.BO
15.61%
S&P BSE SENSEX (^BSESN)
161.32%

Compare To: ZDHJERK.BO

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: ZDHJERK.BO

View More

Valuation Measures

Annual
As of 5/13/2025
  • Market Cap

    79.55M

  • Enterprise Value

    55.65M

  • Trailing P/E

    21.33

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.36

  • Price/Book (mrq)

    0.81

  • Enterprise Value/Revenue

    0.25

  • Enterprise Value/EBITDA

    4.83

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    1.69%

  • Return on Assets (ttm)

    --

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    222.62M

  • Net Income Avi to Common (ttm)

    3.75M

  • Diluted EPS (ttm)

    0.91

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    22.3M

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    --

Research Analysis: ZDHJERK.BO

View More

Company Insights: ZDHJERK.BO

Research Reports: ZDHJERK.BO

View More

People Also Watch